These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9587532)

  • 21. [Lansoprazol ++ : a new proton pump inhibitor].
    Baczek J; Laskowiec G
    Pol Merkur Lekarski; 1998 Jun; 4(24):339-41. PubMed ID: 9771021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-related healing of duodenal ulcer with the proton pump inhibitor lansoprazole.
    Londong W; Barth H; Dammann HG; Hengels KJ; Kleinert R; Müller P; Rohde H; Simon B
    Aliment Pharmacol Ther; 1991 Jun; 5(3):245-54. PubMed ID: 1888824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of lansoprazole and omeprazole in the short-term management of duodenal ulcers in Taiwan.
    Chang FY; Chiang CY; Tam TN; Ng WW; Lee SD
    J Gastroenterol Hepatol; 1995; 10(5):595-601. PubMed ID: 8963037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials.
    Peura DA; Kovacs TO; Metz DC; Siepman N; Pilmer BL; Talley NJ
    Am J Med; 2004 Jun; 116(11):740-8. PubMed ID: 15144910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Helicobacter pylori and digestive hemorrhage due to duodenal ulcer: the prevalence of the infection, the efficacy of 3 triple therapies and the role of eradication in preventing a hemorrhagic recurrence].
    Gisbert JP; Boixeda D; Aller R; de la Serna C; Sanz E; Martín de Argila C; Abraira V; García Plaza A
    Med Clin (Barc); 1999 Feb; 112(5):161-5. PubMed ID: 10091208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment with omeprazole, clarithromycin and amoxicillin over 6 days in patients with Helicobacter pylori-infected duodenal ulcer].
    García-Romero E; del Val A; Garrigues V; Cuquerella J; Higón MD; Barrachina M; Pons V; Bixquert M; Ponce J
    Gastroenterol Hepatol; 1999 Jan; 22(1):1-6. PubMed ID: 10089703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Results of pre- and postoperative treatment of complicated duodenal ulcers with proton pump inhibitors ].
    Cherniakevich SA; Babkova IV; Mikhalev AI
    Klin Med (Mosk); 2002; 80(9):52-4. PubMed ID: 12416227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of three doses of lansoprazole (15, 30 and 60 mg) and placebo in the treatment of duodenal ulcer. The Lansoprazole Study Group.
    Avner DL; Dorsch ER; Jennings DE; Greski-Rose PA
    Aliment Pharmacol Ther; 1995 Oct; 9(5):521-8. PubMed ID: 8580272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute treatment of duodenal ulcer: experience with lansoprazole.
    Mignon M; Vallot T
    Aliment Pharmacol Ther; 1993; 7 Suppl 1():37-40, discussion 61-6. PubMed ID: 8490078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
    Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
    J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastric acid secretion and duodenal ulcer healing during treatment with omeprazole. A Scandinavian Multicentre Study.
    Scand J Gastroenterol; 1984 Oct; 19(7):882-4. PubMed ID: 6397846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lansoprazole versus famotidine: efficacy and tolerance in the acute management of duodenal ulceration.
    Hotz J; Kleinert R; Grymbowski T; Hennig U; Schwarz JA
    Aliment Pharmacol Ther; 1992 Feb; 6(1):87-95. PubMed ID: 1543819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lansoprazole.
    Med Lett Drugs Ther; 1995 Jul; 37(953):63-4. PubMed ID: 7603391
    [No Abstract]   [Full Text] [Related]  

  • 34. Factors affecting quality of ulcer healing after lansoprazole treatment.
    Ito G; Nakagawara M; Watanabe F; Ooi S; Nawano M; Hanai H; Kaneko E
    J Clin Gastroenterol; 1995; 20 Suppl 2():S62-6. PubMed ID: 7594344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lansoprazole versus omeprazole in active duodenal ulcer. A double-blind, randomized, comparative study.
    Ekström P; Carling L; Unge P; Anker-Hansen O; Sjöstedt S; Sellström H
    Scand J Gastroenterol; 1995 Mar; 30(3):210-5. PubMed ID: 7770708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of duodenal ulcer outbreak with omeprazole. Results of a multicenter non-controlled study].
    Blanchi A; Rotenberg A; Soulé JC; Delchier JC; Morin T; Pariente EA; Bitoun A; Modigliani R; Bader JP
    Gastroenterol Clin Biol; 1984 Dec; 8(12):943-6. PubMed ID: 6394418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The newest proton pump inhibitor.
    Claussen DW
    Gastroenterol Nurs; 1995; 18(6):235-6. PubMed ID: 8562590
    [No Abstract]   [Full Text] [Related]  

  • 38. Second proton-pump inhibitor marketed.
    Am J Health Syst Pharm; 1995 Aug; 52(15):1601. PubMed ID: 7583820
    [No Abstract]   [Full Text] [Related]  

  • 39. [Controlled study with ranitidine for the prevention of recurrent duodenal ulcer].
    Ocaña Andrade E; Porras Katz JC; Beltrán Escobar G; Jáuregui Garduño JL
    Rev Gastroenterol Mex; 1997; 62(2):94-7. PubMed ID: 9471669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevacid (lansoprazole).
    Claussen DW
    Gastroenterol Nurs; 1996; 19(4):151-2. PubMed ID: 8852163
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.